Bayer subsidiary doses first patient with Parkinson’s disease cell therapy
German pharma company announces progress in its ‘two-pronged’ cell and gene therapy approach to Parkinson’s disease
Read More
Tag: cell and gene therapy
GSK to leverage the Cell and Gene Therapy Catapult’s facility in Stevenage
British drugmaker to expand its clinical manufacturing capacity for cell and gene therapy
Read More
UK biotech Ixaka scores additional funding for cell and gene therapy research
Lead asset REX-001 is in Phase III development for chronic limb-threatening ischaemia
Read More
Cell Medica given $8.7 million to develop cancer therapy
Cell Medica has been awarded a $8.7 million CPRIT grant to accelerate its CMD-502 cell therapy into clinical development.
Read More
UK surge in cell and gene therapy trials
A surge in cell and gene therapy trials – an increase of 37% since 2017 – highlights the UK’s leading position as a developmental hub in the sector, says the Cell and Gene Therapy Catapult.
Read More
